Dr. Spring is a clinical/translational investigator and breast medical oncologist at the Massachusetts General Hospital Cancer Center and Harvard Medical School. The primary focus of her research is to develop novel therapeutic and biomarker strategies to improve the care of breast cancer patients. She is particularly interested in blood-based monitoring of localized breast cancer and the use of targeted therapies in the neoadjuvant setting. Dr. Spring is the recipient of a Young Investigator Award from the ASCO Conquer Cancer Foundation for her work exploring circulating tumor cell (CTC) monitoring in the neoadjuvant setting in breast cancer. She is involved with the design and conduct of several breast cancer clinical trials for localized and metastatic breast cancer.